510(k) K220231
K220231 is an FDA 510(k) premarket notification submitted by Ultrathera Technologies, Inc. for the device "GyroStim". The FDA issued a decision of Substantially Equivalent on April 27, 2022. The device falls under product code LXV (Apparatus, Vestibular Analysis), a Class U device.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 27, 2022
- Date Received
- January 27, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Apparatus, Vestibular Analysis
- Device Class
- Class U
- Regulation Number
- Review Panel
- EN
- Submission Type